Total Voting Rights

GlaxoSmithKline PLC
01 February 2008



                        Total Voting Rights and Capital


In conformity with Disclosure and Transparency Rule 5.6.1R, GlaxoSmithKline plc
("the Company") hereby notifies the market of the following:

The Company's issued share capital as at 31 January 2008 consisted of
6,015,075,749 Ordinary shares of 25p each with voting rights, of which
504,194,158 Ordinary shares are held in Treasury.

Therefore, the total number of voting rights in the Company is 5,510,881,591.
This figure may be used by shareholders as the denominator for the calculations
by which they will determine if they are required to notify their interest in,
or a change to their interest in, the Company under the Financial Services
Authority's Disclosure and Transparency Rules.


S M Bicknell
Company Secretary

1 February 2008


                      This information is provided by RNS
            The company news service from the London Stock Exchange